An update in the therapy of hepatitis C

Descripción del Articulo

Hepatitis C is a communicable disease caused by 6 genotypes of the hepatitis C virus, and this condition may have a variable response to therapy. Viral particles are 30-38 nm long, they have an envelope and single-stranded RNA. The virus belongs to the Flaviviridae family. Hepatitis C is a severe pu...

Descripción completa

Detalles Bibliográficos
Autor: Díaz Ferrer, Javier
Formato: artículo
Fecha de Publicación:2012
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/1223
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/1223
Nivel de acceso:acceso abierto
Materia:Hepatitis C
public health
therapy
id REVCMP_ce2cfa543bebf1c9dfc14eddd0ffc7a0
oai_identifier_str oai:ojs.pkp.sfu.ca:article/1223
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
spelling An update in the therapy of hepatitis CActualización en el tratamiento de la Hepatitis CDíaz Ferrer, Javier Hepatitis Cpublic healththerapyHepatitis C is a communicable disease caused by 6 genotypes of the hepatitis C virus, and this condition may have a variable response to therapy. Viral particles are 30-38 nm long, they have an envelope and single-stranded RNA. The virus belongs to the Flaviviridae family. Hepatitis C is a severe public health problem. It has been estimated that the rate of infected persons in most of the countries lies between 1,5 to 3 per cent, and its therapy is quite complex.La hepatitis C es una enfermedad infectocontagiosa causada por 6 genotipos del virus del virus del mismo nombre que pueder responder de manera distinta al tratamiento. El virus de 30 a 38 nm de tamaño, posee una envoltura y una sola cadena de ARN (+), pertenciendo a la familia Flaviviridae. La hepatitis C constituye una grave problema de salud pública se calcula que las tasas de infectados en la mayoría de los países se encuentra entre el 1,5 y el 3 %, siendo su tratamiento complejo.Colegio Médico del Perú2012-12-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/1223ACTA MEDICA PERUANA; Vol 29 No 4 (2012); 208-212ACTA MEDICA PERUANA; Vol. 29 Núm. 4 (2012); 208-2121728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/1223/692Copyright (c) 2020 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/12232023-07-06T05:57:55Z
dc.title.none.fl_str_mv An update in the therapy of hepatitis C
Actualización en el tratamiento de la Hepatitis C
title An update in the therapy of hepatitis C
spellingShingle An update in the therapy of hepatitis C
Díaz Ferrer, Javier
Hepatitis C
public health
therapy
title_short An update in the therapy of hepatitis C
title_full An update in the therapy of hepatitis C
title_fullStr An update in the therapy of hepatitis C
title_full_unstemmed An update in the therapy of hepatitis C
title_sort An update in the therapy of hepatitis C
dc.creator.none.fl_str_mv Díaz Ferrer, Javier
author Díaz Ferrer, Javier
author_facet Díaz Ferrer, Javier
author_role author
dc.subject.none.fl_str_mv Hepatitis C
public health
therapy
topic Hepatitis C
public health
therapy
description Hepatitis C is a communicable disease caused by 6 genotypes of the hepatitis C virus, and this condition may have a variable response to therapy. Viral particles are 30-38 nm long, they have an envelope and single-stranded RNA. The virus belongs to the Flaviviridae family. Hepatitis C is a severe public health problem. It has been estimated that the rate of infected persons in most of the countries lies between 1,5 to 3 per cent, and its therapy is quite complex.
publishDate 2012
dc.date.none.fl_str_mv 2012-12-28
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/1223
url https://amp.cmp.org.pe/index.php/AMP/article/view/1223
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/1223/692
dc.rights.none.fl_str_mv Copyright (c) 2020 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol 29 No 4 (2012); 208-212
ACTA MEDICA PERUANA; Vol. 29 Núm. 4 (2012); 208-212
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1816075105326858240
score 13.904009
An update in the therapy of hepatitis C
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares